SORBA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 2.318
EU - Europa 2.189
AS - Asia 1.208
SA - Sud America 182
Continente sconosciuto - Info sul continente non disponibili 87
AF - Africa 17
Totale 6.001
Nazione #
US - Stati Uniti d'America 2.245
RU - Federazione Russa 466
IE - Irlanda 406
CN - Cina 376
SG - Singapore 313
DE - Germania 311
SE - Svezia 228
IT - Italia 212
UA - Ucraina 166
HK - Hong Kong 156
VN - Vietnam 145
BR - Brasile 134
FI - Finlandia 122
FR - Francia 89
IN - India 78
GB - Regno Unito 60
CA - Canada 42
TR - Turchia 39
EE - Estonia 31
CZ - Repubblica Ceca 27
AR - Argentina 18
BE - Belgio 18
PL - Polonia 16
BD - Bangladesh 14
MX - Messico 14
IR - Iran 13
JP - Giappone 13
ES - Italia 10
KR - Corea 10
CL - Cile 8
IQ - Iraq 8
PK - Pakistan 8
EC - Ecuador 7
ID - Indonesia 7
EU - Europa 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
LT - Lituania 5
VE - Venezuela 5
ZA - Sudafrica 5
AT - Austria 4
HN - Honduras 4
MD - Moldavia 4
PE - Perù 4
GR - Grecia 3
NI - Nicaragua 3
PH - Filippine 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CO - Colombia 2
GA - Gabon 2
MA - Marocco 2
MY - Malesia 2
NL - Olanda 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
MQ - Martinica 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 5.920
Città #
Dublin 406
Jacksonville 299
San Jose 199
Dearborn 157
Hong Kong 156
Beijing 132
Singapore 114
Ann Arbor 106
Ashburn 104
Chandler 87
Council Bluffs 83
Wilmington 78
Piemonte 76
Moscow 55
Munich 54
Lawrence 51
Princeton 51
Los Angeles 50
Columbus 49
San Mateo 49
Lauterbourg 44
Ho Chi Minh City 42
New York 41
Andover 35
Santa Clara 34
Hanoi 30
Brno 27
Buffalo 22
Ankara 21
Phoenix 21
Bremen 20
Helsinki 20
São Paulo 18
Brussels 16
Frankfurt am Main 16
Toronto 14
Warsaw 14
Dallas 13
Turku 13
Orem 12
Denver 11
Tokyo 11
Boston 10
Chennai 10
Houston 10
Kunming 10
Milan 10
Montreal 10
Redondo Beach 10
Tianjin 10
Chicago 9
Hefei 9
London 9
Nanjing 9
Kocaeli 8
North Bergen 8
Norwalk 8
Seoul 8
St Louis 8
Woodbridge 8
Atlanta 7
Grignasco 7
Kecioeren 7
Nanchang 7
Philadelphia 7
San Francisco 7
Stockholm 7
Dong Ket 6
Formigine 6
Monmouth Junction 6
Novara 6
Nuremberg 6
Poplar 6
Biên Hòa 5
Boardman 5
Brooklyn 5
Can Tho 5
Chengdu 5
Fairfield 5
Guayaquil 5
Haiphong 5
Jinan 5
Noicattaro 5
Torino 5
Turin 5
Baghdad 4
Berlin 4
Changsha 4
Falkenstein 4
Hangzhou 4
Las Vegas 4
Mexico City 4
Paris 4
Shanghai 4
Shenyang 4
Zanjan 4
Ardabil 3
Athens 3
Augusta 3
Bexley 3
Totale 3.216
Nome #
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 187
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 183
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 174
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 174
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 171
Are 1,4- and 1,5-Disubstituted 1,2,3-Triazoles Good Pharmacophoric Groups? 167
A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Antitubulin Agents 165
A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies 161
Capitolo 23. Istamina e agenti antistaminici 156
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs 148
The Guareschi Pyridine Scaffold as a Valuable Platform for the Identification of Selective PI3K Inhibitors 144
Estrogenic analogues synthesized by click chemistry 143
Groebke multicomponent reaction and subsequent nucleophilic aromatic substitution for a convenient synthesis of 3,8-diaminoimidazo[1,2-a]pyrazines as potential kinase inhibitors 142
Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases 132
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 130
A practical synthesis of 5-aroyl-1-aryltetrazoles using an Ugi-like 4-component reaction followed by a biomimetic transamination 130
Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes 127
Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase 124
De novo computer-aided design of novel antiviral agents 124
Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus 123
Anti-Helicobacter pylori agents endowed with H2-antagonist properties 122
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage 122
Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry 117
Replacement of the double bond of antitubulin chalcones with triazoles and tetrazoles: synthesis and biological evaluation 117
A new furoxan NO-donor rabeprazole derivative and related compounds 117
Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2 116
In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors 116
Essential role of the p110β subunit of phosphoinositide 3-OH kinase in male fertility 115
Triazole-modified histone deacetylase inhibitors as a rapid route to drug discovery 115
Icilio Guareschi and his amazing “1897 reaction” 112
[3-(1H-Imidazol-4-yl)propyl]guanidines containing furoxan moieties: a New Class of H3-Antagonists endowed with NO-Donor properties 110
Synthesis and pharmacological characterization of new H2-antagonists containing NO-donor moieties, endowed with mixed antisecretory and gastroprotective activities 106
Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylase 106
Solution-phase parallel synthesis and biological evaluation of combretatriazoles 105
Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents 104
ZINClick: A Database of 16 Million Novel, Patentable, and Readily Synthesizable 1,4-Disubstituted Triazoles 100
Synthesis and biological evaluation of combretatriazoles 98
Furoxan Analogues of the Histamine H3 receptor antagonist imoproxifan and related furazan derivatives 95
“Synthesis and in vitro evaluation of tetrasubstituted pyridines as potential PI3Ks inhibitors” 93
Synthesis and anti-Helicobacter pylori properties of NO-donor/metronidazole hybrids and related compounds 88
Synthesis and cytotoxic evaluation of combretafurazans 85
“Identification of the first selective Sirt3 inhibitor”, 85
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 82
The tubulin colchicine domain: a molecular modelling perspective 82
Molecular Field Analysis and 3D-Quantitative Structure-Activity Relationship Studies (MFA 3D-QSAR) of Bile Acids and Fexaramine Derivatives as Agonists of Farnesoid X Receptor (FXR) 78
Medicinal chemistry of combretastatin A4: present and future directions 77
In search of novel antitubulin agents: synthesis of 1-aryl-5-aroyl tetrazoles by an Ugi 4-CR/hydrogenolysis/transamination reaction 72
Rapid synthesis of triazole-modified resveratrol analogues via click chemistry 67
Role of the nicotinic acid group in NAADP receptor selectivity 66
NO-donors: focus on furoxan derivatives 66
Unsymmetrically substituted furoxans. Part 18. Smiles rearrangement in furoxan systems and in related furazans 62
Totale 6.001
Categoria #
all - tutte 28.658
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.658


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022303 0 0 0 48 19 1 40 8 20 22 50 95
2022/2023869 59 40 64 17 60 87 29 51 416 3 23 20
2023/2024230 22 16 23 13 45 0 54 4 1 0 17 35
2024/2025601 15 16 37 5 26 52 60 35 125 85 18 127
2025/20261.984 127 54 142 307 178 126 237 347 126 189 119 32
2026/2027421 49 146 91 135 0 0 0 0 0 0 0 0
Totale 6.001